What changed
$OXY — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $5.2B | EPS $1.06 vs $0.59 🟢
💡 Consensus may extrapolate the EPS surprise and debt reduction narrative, but the market is overestimating earnings sustainability. Variant view: normalized EPS is significantly lower ($0.50-0.70/qtr), free cash flow remains negative, and the debt reduction pace will slow without asset sales or higher oil prices, leading to a re-rating downward.
📉 Reward/risk: 0.7:1
🏢 Business Quality: 4/10
📊 Valuation: rich - trailing P/E distorted (53x on annualized GAAP EPS but likely >20x on normalized), EV/EBITDA estimated >10x vs.
🔮 Catalyst: Q2 2026 earnings release
💰 Entry: $56.54, stop $45.23, target $48.76
⚖️ Avoid: OXY's headline beat is hollow; normalized earnings are far lower, FCF is negative, and valuation is rich.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/OXY0613